VANGUARD GROUP INC 13D and 13G filings for Global Blood Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-10 08:11 am Purchase | 2021-12-31 | 13G | Global Blood Therapeutics, Inc. GBT | VANGUARD GROUP INC | 5,993,142 9.300% | 532,660 (+9.75%) | Filing |
| 2021-02-10 10:57 am Sale | 2020-12-31 | 13G | Global Blood Therapeutics, Inc. GBT | VANGUARD GROUP INC | 5,460,482 8.840% | -10,980 (-0.20%) | Filing |